UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in a sample of early-onset psychosis

European psychiatry, 2023-03, Vol.66 (S1), p.S443-S444

2023

Volltextzugriff (PDF)

Maternal depression symptoms, unhealthy diet and child emotional–behavioural dysregulation

Psychological medicine, 2015-07, Vol.45 (9), p.1851-1860

2015

Volltextzugriff (PDF)

Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

Journal of autism and developmental disorders, 2020-08, Vol.50 (8), p.3046-3059

2020

Volltextzugriff (PDF)

Biomarkers of oxidative stress and inflammation in urine samples of extremely preterm newborns and their association with risk for autism at age 6 months

European psychiatry, 2023-03, Vol.66 (S1), p.S585-S585

2023

Volltextzugriff (PDF)

Insular pathology in young people with high-functioning autism and first-episode psychosis

Psychological medicine, 2017-10, Vol.47 (14), p.2472-2482

2017

Volltextzugriff (PDF)

Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes

The world journal of biological psychiatry, 2022-03, Vol.23 (3), p.208-218

2022

Volltextzugriff (PDF)

P.7.b.018 Maternal depression symptoms, unhealthy diet and child emotional–behavioural dysregulation

European neuropsychopharmacology, 2014-10, Vol.24, p.S716-S717

2014

Volltextzugriff (PDF)

P.7.f.008 Social cognition structural neuroimaging in adolescents with high-functioning autism and first episode of psychosis

European neuropsychopharmacology, 2014-10, Vol.24, p.S733-S733

2014

Volltextzugriff (PDF)

Predictors of multiple treatment failure of antipsychotics in early-onset psychosis

European neuropsychopharmacology, 2016-10, Vol.26, p.S539-S540

2016

Volltextzugriff (PDF)

Short-term weight gain in antipsychotic-naïve pediatric and adult patients with psychosis treated with second-generation antipsychotics

European neuropsychopharmacology, 2016-10, Vol.26, p.S570-S570

2016

Volltextzugriff (PDF)

P.1.016 Role of leptin and adiponectin in weight gain related to second-generation antipsychotics

European neuropsychopharmacology, 2014-03, Vol.24, p.S16-S17

2014

Volltextzugriff (PDF)

P.7.b.009 Predictors of weight gain after six months of treatment with second-generation antipsychotics in pediatric and adult patients

European neuropsychopharmacology, 2014-10, Vol.24, p.S710-S711

2014

Volltextzugriff (PDF)

P.7.b.017 Premorbid to post-morbid functional adjustment course in adolescents after a first episode psychosis

European neuropsychopharmacology, 2014-10, Vol.24, p.S715-S716

2014

Volltextzugriff (PDF)

P.3.012 Predictors of second-generation antipsychotic-induced weight gain: a longitudinal study on antipsychotic-naive patients

European neuropsychopharmacology, 2014-03, Vol.24, p.S64-S65

2014

Volltextzugriff (PDF)

P.7.b.004 Influence of duration of untreated psychosis (DUP) on functional outcome in youth with first episode psychosis: a 2-year longitudinal study

European neuropsychopharmacology, 2013-10, Vol.23, p.S587-S588

2013

Volltextzugriff (PDF)

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis

Schizophrenia bulletin, 2019-01, Vol.45 (1), p.57-68

2019

Volltextzugriff (PDF)

EPA-0863 - Progression of changes in brain structure and executive functions in children and adolescents with first-episode psychosis

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

P.3.023 Metabolic risk after six months of treatment with second-generation antipsychotics in antipsyehotic-naïve children and adolescents

European neuropsychopharmacology, 2012-03, Vol.22, p.S71-S72

2012

Volltextzugriff (PDF)

EPA-0882 - Prediction of diagnosis of early-onset schizophrenia spectrum disorders using support vector machines

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

P.7.c.007 Insulin resistance and metabolic risk related to second-generation antipsychotics in antipsychotic-naïve pediatric and adult patients

European neuropsychopharmacology, 2012-10, Vol.22, p.S430-S430

2012

Volltextzugriff (PDF)

P.7.a.009 Predictors of diagnosis of nonaffective acute remitting psychosis in patients with early-onset first episodes of psychosis

European neuropsychopharmacology, 2012-10, Vol.22, p.S418-S419

2012

Volltextzugriff (PDF)

P.3.004 Risk for adverse health outcome in antipsychotic-naïve adolescents after 12 months of treatment with second-generation antipsychotics

European neuropsychopharmacology, 2011, Vol.21, p.S61-S62

2011

Volltextzugriff (PDF)

P.7.c.003 Obesogenic capacity of second-generation antipsychotics in naïve-adolescents and their impact on leptin, adiponectin and ghrelin

European neuropsychopharmacology, 2011, Vol.21, p.S605-S606

2011

Volltextzugriff (PDF)

Quality of life and psychiatric comorbidities in pediatric patients with Gilles de la Tourette syndrome

Revista de neurologiá, 2021-11, Vol.73 (10), p.339-344

2021

Volltextzugriff (PDF)

P.0756 Network-level structural biomarkers of diagnostic prognosis in first-episode psychosis

European neuropsychopharmacology, 2021-12, Vol.53, p.S550-S551

2021

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in a sample of early-onset psychosis

Maternal depression symptoms, unhealthy diet and child emotional–behavioural dysregulation

Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

Biomarkers of oxidative stress and inflammation in urine samples of extremely preterm newborns and their association with risk for autism at age 6 months

Insular pathology in young people with high-functioning autism and first-episode psychosis

Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes

P.7.b.018 Maternal depression symptoms, unhealthy diet and child emotional–behavioural dysregulation

P.7.f.008 Social cognition structural neuroimaging in adolescents with high-functioning autism and first episode of psychosis

Predictors of multiple treatment failure of antipsychotics in early-onset psychosis

Short-term weight gain in antipsychotic-naïve pediatric and adult patients with psychosis treated with second-generation antipsychotics

P.1.016 Role of leptin and adiponectin in weight gain related to second-generation antipsychotics

P.7.b.009 Predictors of weight gain after six months of treatment with second-generation antipsychotics in pediatric and adult patients

P.7.b.017 Premorbid to post-morbid functional adjustment course in adolescents after a first episode psychosis

P.3.012 Predictors of second-generation antipsychotic-induced weight gain: a longitudinal study on antipsychotic-naive patients

P.7.b.004 Influence of duration of untreated psychosis (DUP) on functional outcome in youth with first episode psychosis: a 2-year longitudinal study

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis

EPA-0863 - Progression of changes in brain structure and executive functions in children and adolescents with first-episode psychosis

P.3.023 Metabolic risk after six months of treatment with second-generation antipsychotics in antipsyehotic-naïve children and adolescents

EPA-0882 - Prediction of diagnosis of early-onset schizophrenia spectrum disorders using support vector machines

P.7.c.007 Insulin resistance and metabolic risk related to second-generation antipsychotics in antipsychotic-naïve pediatric and adult patients

P.7.a.009 Predictors of diagnosis of nonaffective acute remitting psychosis in patients with early-onset first episodes of psychosis

P.3.004 Risk for adverse health outcome in antipsychotic-naïve adolescents after 12 months of treatment with second-generation antipsychotics

P.7.c.003 Obesogenic capacity of second-generation antipsychotics in naïve-adolescents and their impact on leptin, adiponectin and ghrelin

Quality of life and psychiatric comorbidities in pediatric patients with Gilles de la Tourette syndrome

P.0756 Network-level structural biomarkers of diagnostic prognosis in first-episode psychosis

Suchergebnisse filtern